Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Research Article, J Liver Dis Transplant Vol: 2 Issue: 1
The Effectiveness of Venesection Therapy for Haemochromatosis Symptoms
| O Niewiadomski1, A Rode1, N Bertalli2, L Gurrin2, K Allen3 and AJ Nicoll1* | |
| 1Department of Gastroenterology and Hepatology, Royal Melbourne Hospital, Melbourne, Australia | |
| 2Centre for MEGA Epidemiology, The University of Melbourne, Australia | |
| 3Murdoch Childrens Research Institute, Melbourne, Australia | |
| Corresponding author : Amanda J Nicoll Department of Gastroenterology and Hepatology, Royal Melbourne Hospital, PO Box RMH, VIC. 3050, Australia Tel: 61-3-9342-7789; Fax: 61-3-9342-7848 E-mail: Amanda.Nicoll@mh.org.au |
|
| Received: January 17, 2013 Accepted: March 16, 2013 Published: March 20, 2013 | |
| Citation: Niewiadomski O, Rode A, Bertalli N, Gurrin L, Allen K, Nicoll AJ (2013) The Effectiveness of Venesection Therapy for Haemochromatosis Symptoms. J Liver: Dis Transplant 2:1. doi:10.4172/2325-9612.1000107 |
Abstract
The Effectiveness of Venesection Therapy for Haemochromatosis Symptoms
Hereditary haemochromatosis (HH) is an autosomal recessive disorder, characterized by iron overload, and it is the commonest genetic condition affecting people of northern European ancestry. In most HH cases (>90%), a homozygous C282Y missense mutation on the HFE gene is the causeThe aim of this study was to determine if (1) the main symptoms of haemochromatosis, fatigue and arthritis, are improved by venesection therapy, and (2) to determine the number of venesections required to reach the target ferritin level.
